Russian President Vladimir Putin announced on Wednesday that Russian scientists were on the verge of introducing vaccines for cancer, which could soon become accessible to patients.
Speaking at a Moscow forum on future technologies, Putin stated that they were nearing the development of “cancer vaccines and immunomodulatory drugs of a new generation.” He expressed hope that these treatments would soon be utilized effectively in individual therapy.
However, Putin did not specify the types of cancer these vaccines would target or the methods involved.
Various countries and companies worldwide are also engaged in the development of cancer vaccines. For instance, the UK government partnered with BioNTech from Germany to launch clinical trials for personalized cancer treatments, aiming to benefit 10,000 patients by 2030.
Moreover, pharmaceutical companies such as Moderna and Merck & Co are working on experimental cancer vaccines. A mid-stage study showed that one of their vaccines reduced the chance of recurrence or death from melanoma, the deadliest form of skin cancer, by half after three years of treatment.
Currently, there are six licensed vaccines against human papillomaviruses (HPV), which are linked to several cancers, including cervical cancer. Additionally, vaccines against hepatitis B (HBV), a cause of liver cancer, are available.
During the COVID-19 pandemic, Russia developed the Sputnik V vaccine against the virus and distributed it to numerous countries. However, it faced vaccine hesitancy domestically. Putin himself publicly received the Sputnik V vaccine to reassure people about its effectiveness and safety.
Be First to Comment